Client #1

80 y/o male, recently (4-15-21) diagnosed with PD

Using the Cognivue FDA recognized cognitive assessment modality, #1 was tested and scored an 58 on 11-17-2021. This score would indicate low cognitive impairment.
We intervened with a variety of balance and engagement exercise, including the computerized, FDA recognized Korebalance balance assessment and training device, the Cybercycle engagement exercise recumbent cycle, the Power Plate WBV modality, and the Fight master targeted striking device.

Tasks were performed on these devices for an average of one hour, once a week. Client #1 also participated in a once a week circuit strength training regimen with Nautilus ONE equipment.
Retest on the Cognivue was performed on 8-12-2021, with client achieving a score of 62, 6.5% improvement.

Significant improvement was documented in executive function, naming and language, delayed recall, and abstraction.

Client continues to participate in the program and will be retested early 2022.

Client #2

70 y/o male, living with Parkinson’s for 14 years

Is a client of Rock Steady Boxing, trains 2x/week and member of a PD support group.

Client presented with PD, Dystonia that affected posture, and gait difficulty.

Using the Cognivue FDA recognized cognitive assessment modality, #2 was tested and scored an 18 on 11-17-2021. This score would indicate severe cognitive impairment.

We intervened with a variety of balance and engagement exercise, including the computerized, FDA recognized Korebalance balance assessment and training device, the Cybercycle engagement exercise recumbent cycle, the Power Plate WBV modality, and the Fight master targeted striking device.

We also implemented a strength training and posture improvement program using Nautilus ONE strength equipment. The client performed 5 exercise- neck flexion, side bending right and left, mid rows, and lat pulls.

Tasks were performed on these devices for an average of one hour, once a week.

Retest on the Cognivue was performed on 12-15-2021, with client achieving a score of 23, 22% improvement.

Significant improvement was recognized in executive function, naming and language, memory, and delayed recall.

Client is continuing in the program and will be retested early 2022.

Definitive conclusions cannot be made from two short term case studies, however these outcomes re-enforce the study results showing that aggressive, high intensity engagement exercise and multi-tasking seem to create increased acuity, even with clients that have had neurodegenerative disease for long period. The Cognivue device, for the first time has allowed us to baseline and assess progression or regression granularly, and should open the door for peer reviewed RCT’s and establishment of enhanced standard of care.